» Articles » PMID: 20219824

Regulated Oxygen Sensing by Protein Hydroxylation in Renal Erythropoietin-producing Cells

Overview
Specialties Nephrology
Physiology
Date 2010 Mar 12
PMID 20219824
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney is a major site of systemic oxygen sensing, regulating blood erythrocyte and hence oxygen content by hypoxia-inducible erythropoietin (Epo) expression. A constant ratio between blood perfusion and oxygen consumption, a stable corticomedullary oxygen gradient, and a relatively low tissue Po(2) are the prerequisites for the function of renal Epo-producing and oxygen-sensing (REPOS) cells, which are located in the juxtamedullary cortex. In kidney disease, renal oxygen consumption is decreased, leading to an increase in Po(2), dysfunction of REPOS cells, and anemia. The molecular principles of cellular oxygen sensing have been elucidated in the last few years, and genetically altered mouse models as well as hereditary diseases causing erythrocytosis have clarified the oxygen-signaling cascade leading to increased Epo expression in REPOS cells. However, the consequences of a number of recently discovered factors for the regulation of oxygen signaling in REPOS cells are unclear, asking for novel cell culture models which might be hampered by the putative neuron-like nature of this enigmatic cell type.

Citing Articles

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review.

Waheed Y, Liu J, Almayahe S, Sun D Front Nephrol. 2025; 4:1511596.

PMID: 39763572 PMC: 11701237. DOI: 10.3389/fneph.2024.1511596.


Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?.

Bond P, Verdegaal T, Smit D Endocr Connect. 2024; 13(10).

PMID: 39212549 PMC: 11466264. DOI: 10.1530/EC-24-0283.


Tissue Iron Distribution in Anemic Patients with End-Stage Kidney Disease: Results of a Pilot Study.

Lanser L, Plaikner M, Fauser J, Petzer V, Denicolo S, Haschka D J Clin Med. 2024; 13(12).

PMID: 38930016 PMC: 11204586. DOI: 10.3390/jcm13123487.


Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming.

Rahbar Saadat Y, Hosseiniyan Khatibi S, Sani A, Zununi Vahed S, Ardalan M Inflammopharmacology. 2023; 31(4):1657-1669.

PMID: 37131045 DOI: 10.1007/s10787-023-01232-x.


CIRP attenuates acute kidney injury after hypothermic cardiovascular surgery by inhibiting PHD3/HIF-1α-mediated ROS-TGF-β1/p38 MAPK activation and mitochondrial apoptotic pathways.

Zhang P, Bai L, Tong Y, Guo S, Lu W, Yuan Y Mol Med. 2023; 29(1):61.

PMID: 37127576 PMC: 10152741. DOI: 10.1186/s10020-023-00655-0.